WO2014195900A3 - Composiciones farmacéuticas orales para uso en dislipidemias - Google Patents
Composiciones farmacéuticas orales para uso en dislipidemias Download PDFInfo
- Publication number
- WO2014195900A3 WO2014195900A3 PCT/IB2014/061987 IB2014061987W WO2014195900A3 WO 2014195900 A3 WO2014195900 A3 WO 2014195900A3 IB 2014061987 W IB2014061987 W IB 2014061987W WO 2014195900 A3 WO2014195900 A3 WO 2014195900A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oral pharmaceutical
- dyslipidemias
- pharmaceutical compositions
- levels
- producing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención comprende una composición farmacéutica oral sólida que contiene una estatina y otro agente antilipidémico, así como un procedimiento para su preparación y el uso de dicha combinación para la elaboración de una formulación farmacéutica útil en el tratamiento de síndrome metabólico, diabetes tipo II, u otras enfermedades. La invención también se refiere al uso de una combinación farmacéutica formada por atorvastatina y fenofibrato, para preparar un medicamento útil para elevar los niveles de HDL2a y HDL2b, y para disminuir los niveles de HDL3a, HDL3b y HDL3c.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2013006332A MX2013006332A (es) | 2013-06-05 | 2013-06-05 | Composiciones farmaceuticas orales para uso en dislipidemias. |
MXMX/A/2013/006332 | 2013-06-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2014195900A2 WO2014195900A2 (es) | 2014-12-11 |
WO2014195900A3 true WO2014195900A3 (es) | 2015-02-05 |
Family
ID=52008666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2014/061987 WO2014195900A2 (es) | 2013-06-05 | 2014-06-05 | Composiciones farmacéuticas orales para uso en dislipidemias |
Country Status (2)
Country | Link |
---|---|
MX (1) | MX2013006332A (es) |
WO (1) | WO2014195900A2 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230079187A (ko) | 2020-09-29 | 2023-06-05 | 라보라토리오스 실레인즈, 에스.에이. 드 씨.브이. | 고지혈증 및 심혈관 질환의 치료 및 예방을 위한 스타틴 및 피브레이트의 약학적 병용 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001037831A1 (en) * | 1999-11-09 | 2001-05-31 | Demetrius Spyriounis | PHARMACEUTICAL COMBINATION COMPRISING SEPARATE DOSAGE FORMS IN A COMPLIANCE PACKAGE OF AN INHIBITOR OF HMG CoA REDUCTASE AND FIBRIC ACID DERIVATIVE |
WO2002024169A1 (en) * | 2000-09-20 | 2002-03-28 | Skyepharma Canada Inc. | Spray drying process and compositions of fenofibrate |
WO2006134604A1 (en) * | 2005-06-15 | 2006-12-21 | Hetero Drugs Limited | Combination composition of cholesterol absorption inhibitor and 3-hydroxy-3-methylglutaryl-coenzyme a (hmg-coa) reductase inhibitor |
US20070014846A1 (en) * | 2003-10-10 | 2007-01-18 | Lifecycle Pharma A/S | Pharmaceutical compositions comprising fenofibrate and atorvastatin |
US20070197602A1 (en) * | 2004-02-09 | 2007-08-23 | Hashime Kanazawa | Combined pharmaceutical composition |
WO2009147009A2 (en) * | 2008-06-06 | 2009-12-10 | Nicox S.A. | Compositions comprising atorvastatin 4-(nitrooxy) butyl ester and a hypolipidemic drug |
WO2011002422A2 (en) * | 2009-07-02 | 2011-01-06 | Bilgic Mahmut | Solubility enhancing pharmaceutical formulation |
US20110027371A1 (en) * | 1998-10-01 | 2011-02-03 | Elan Pharma International Limited | Nanoparticulate statin formulations and novel statin combinations |
-
2013
- 2013-06-05 MX MX2013006332A patent/MX2013006332A/es unknown
-
2014
- 2014-06-05 WO PCT/IB2014/061987 patent/WO2014195900A2/es active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110027371A1 (en) * | 1998-10-01 | 2011-02-03 | Elan Pharma International Limited | Nanoparticulate statin formulations and novel statin combinations |
WO2001037831A1 (en) * | 1999-11-09 | 2001-05-31 | Demetrius Spyriounis | PHARMACEUTICAL COMBINATION COMPRISING SEPARATE DOSAGE FORMS IN A COMPLIANCE PACKAGE OF AN INHIBITOR OF HMG CoA REDUCTASE AND FIBRIC ACID DERIVATIVE |
WO2002024169A1 (en) * | 2000-09-20 | 2002-03-28 | Skyepharma Canada Inc. | Spray drying process and compositions of fenofibrate |
US20070014846A1 (en) * | 2003-10-10 | 2007-01-18 | Lifecycle Pharma A/S | Pharmaceutical compositions comprising fenofibrate and atorvastatin |
US20070197602A1 (en) * | 2004-02-09 | 2007-08-23 | Hashime Kanazawa | Combined pharmaceutical composition |
WO2006134604A1 (en) * | 2005-06-15 | 2006-12-21 | Hetero Drugs Limited | Combination composition of cholesterol absorption inhibitor and 3-hydroxy-3-methylglutaryl-coenzyme a (hmg-coa) reductase inhibitor |
WO2009147009A2 (en) * | 2008-06-06 | 2009-12-10 | Nicox S.A. | Compositions comprising atorvastatin 4-(nitrooxy) butyl ester and a hypolipidemic drug |
WO2011002422A2 (en) * | 2009-07-02 | 2011-01-06 | Bilgic Mahmut | Solubility enhancing pharmaceutical formulation |
Also Published As
Publication number | Publication date |
---|---|
MX2013006332A (es) | 2014-12-19 |
WO2014195900A2 (es) | 2014-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016500216A1 (en) | Stable pharmaceutical composition and methods of using same | |
WO2013158680A3 (en) | Compositions and methods comprising celecoxib or related compounds and dextromethorphan | |
EA201690107A1 (ru) | Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе | |
WO2014205389A8 (en) | Nuclear transport modulators and uses thereof | |
MX366175B (es) | Composiciones fosfolipidicas terapeuticas concentradas. | |
WO2014143964A3 (en) | Novel analgesic compositions | |
WO2011141685A3 (fr) | Compositions nasales a visee systemique a base de cocoyl proline ou d'au moins un de ses constituants | |
TN2015000371A1 (en) | Substituted imidazopyridazines | |
WO2011104652A3 (en) | Veterinary compositions | |
MX340985B (es) | Compuestos de n-heteroarilo. | |
MX360554B (es) | Composiciones que comprenden y metodos que utilizan inhibidores de co-transportadores de glucosa-sodio 1 y 2. | |
WO2015056094A3 (en) | Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent | |
WO2014153009A3 (en) | Thiosaccharide mucolytic agents | |
UA116889C2 (uk) | Фармацевтична композиція, що містить суміш ізоформ apg101 (cd95-fc) | |
WO2014107730A3 (en) | Use of fatty acid niacin conjugates for treating diseases | |
WO2014203275A3 (en) | An improved process for the preparation of apixaban and intermediates thereof | |
PH12016500054A1 (en) | Substituted pyrazolo-pyridinamines | |
MX2015000179A (es) | Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas. | |
PH12015501377A1 (en) | Solid unit with high fexofenadine content and process for the preparation thereof | |
PH12015502706B1 (en) | Oral formulation for the treatment of cardiovascular diseases | |
MX2013013079A (es) | Composiciones que comprenden un agente antibacterial y tazobactam. | |
MX359887B (es) | Composicion masticable para administracion oral y proceso para preparar la misma. | |
EP2594268A4 (en) | ANGIOGENIC INHIBITORY COMPOSITION WITH MACROLACTIN A AND A DERIVATIVELY AS ACTIVE SUBSTANCES | |
WO2014195900A3 (es) | Composiciones farmacéuticas orales para uso en dislipidemias | |
WO2015065628A3 (en) | Laquinimod combination therapy for treatment of multiple sclerosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14807715 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14807715 Country of ref document: EP Kind code of ref document: A2 |